Chugai Pharmaceutical Co., Ltd. (CHGCY)
USD 21.75
(-4.1%)
USD 21.75
(-4.1%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1111.36 Billion | 1259.94 Billion | 999.75 Billion | 786.94 Billion | 686.18 Billion | 579.78 Billion |
| Cost of Revenue | 418.35 Billion | 476.25 Billion | 338.14 Billion | 273.46 Billion | 266.07 Billion | 262.84 Billion |
| Gross Profit | 693 Billion | 783.69 Billion | 661.61 Billion | 513.48 Billion | 420.11 Billion | 316.94 Billion |
| Operating Expenses | 258.88 Billion | 250.38 Billion | 239.71 Billion | 212.25 Billion | 209.51 Billion | 192.61 Billion |
| Selling, General and Administrative Expenses | 112.58 Billion | 100.76 Billion | 102.41 Billion | 94.4 Billion | 101.57 Billion | 93.41 Billion |
| Research and Development Expenses | 174.86 Billion | 149.62 Billion | 137.29 Billion | 117.85 Billion | 107.94 Billion | 99.2 Billion |
| Other Expenses | -28.56 Billion | -2.13 Billion | -2.54 Billion | -1.5 Billion | -3.12 Billion | -3.21 Billion |
| Cost and Expenses | 672.19 Billion | 726.63 Billion | 577.86 Billion | 485.71 Billion | 475.58 Billion | 455.46 Billion |
| Operating Income | 439.17 Billion | 533.3 Billion | 421.89 Billion | 301.23 Billion | 210.59 Billion | 124.32 Billion |
| Interest Expense | - | 61 Million | 48 Million | 62 Million | 125 Million | 111 Million |
| Income Tax Expense | 118.34 Billion | 156.73 Billion | 116.39 Billion | 83.45 Billion | 50.33 Billion | 28.37 Billion |
| Earnings before Tax | 443.82 Billion | 531.16 Billion | 419.38 Billion | 298.18 Billion | 207.89 Billion | 121.44 Billion |
| Net Income | 325.47 Billion | 374.42 Billion | 302.99 Billion | 214.73 Billion | 157.56 Billion | 92.48 Billion |
| Earnings Per Share Basic | 197.80 | 227.64 | 184.29 | 130.66 | 95.95 | 28.12 |
| Earnings Per Share Diluted | 197.80 | 227.57 | 184.17 | 130.53 | 95.81 | 28.12 |
| Weighted Average Shares Outstanding | 1.64 Billion | 1.64 Billion | 1.64 Billion | 1.64 Billion | 1.64 Billion | 3.28 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.64 Billion | 1.64 Billion | 1.64 Billion | 1.64 Billion | 1.64 Billion | 3.28 Billion |
| Gross Margin | 0.62 | 0.62 | 0.66 | 0.65 | 0.61 | 0.55 |
| EBIT Margin | 0.40 | 0.42 | 0.42 | 0.38 | 0.30 | 0.21 |
| Profit Margin | 0.29 | 0.30 | 0.30 | 0.27 | 0.23 | 0.16 |
| EBITDA | 443.84 Billion | 531.22 Billion | 419.43 Billion | 298.25 Billion | 208.01 Billion | 121.56 Billion |
| Earnings Before Tax Margin | 0.40 | 0.42 | 0.42 | 0.38 | 0.31 | 0.21 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 315.91 Billion | 236.94 Billion | 273.81 Billion | 1111.36 Billion | 257.89 Billion | 267.41 Billion |
| Cost of Revenue | 87.94 Billion | 72.95 Billion | 92.06 Billion | 418.35 Billion | 78.25 Billion | 91.66 Billion |
| Gross Profit | 227.97 Billion | 163.99 Billion | 181.75 Billion | 693 Billion | 179.64 Billion | 175.75 Billion |
| Operating Expenses | 68.25 Billion | 62.44 Billion | 67.41 Billion | 277.34 Billion | 72.95 Billion | 63.14 Billion |
| Selling, General and Administrative Expenses | 25.31 Billion | 21.18 Billion | 25.55 Billion | - | 27.54 Billion | 33.26 Billion |
| Research and Development Expenses | 42.93 Billion | 41.26 Billion | 41.85 Billion | - | 45.57 Billion | 44.57 Billion |
| Other Expenses | -4 Million | 88 Million | -1.39 Billion | - | - | - |
| Cost and Expenses | 156.19 Billion | 135.39 Billion | 159.47 Billion | 695.7 Billion | 151.21 Billion | 154.8 Billion |
| Operating Income | 159.71 Billion | 101.55 Billion | 114.33 Billion | 415.66 Billion | 106.68 Billion | 112.61 Billion |
| Interest Expense | - | 3 Million | 8 Million | 27 Million | 7 Million | 9 Million |
| Income Tax Expense | 46.94 Billion | 25.48 Billion | 31.48 Billion | 118.34 Billion | 29.9 Billion | 30.8 Billion |
| Earnings before Tax | 158.8 Billion | 99.88 Billion | 122.69 Billion | 443.82 Billion | 107.47 Billion | 113.99 Billion |
| Net Income | 111.86 Billion | 74.4 Billion | 91.2 Billion | 325.47 Billion | 77.57 Billion | 83.19 Billion |
| Earnings Per Share Basic | 67.98 | 45.22 | 55.43 | - | 47.15 | 50.57 |
| Earnings Per Share Diluted | 67.97 | 45.21 | 55.43 | - | 47.14 | 50.56 |
| Weighted Average Shares Outstanding | 1.64 Billion | 1.64 Billion | 1.64 Billion | 1.64 Billion | 1.64 Billion | 1.64 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.64 Billion | 1.64 Billion | 1.64 Billion | 1.64 Billion | 1.64 Billion | 1.64 Billion |
| Gross Margin | 0.72 | 0.69 | 0.66 | 0.62 | 0.70 | 0.66 |
| EBIT Margin | 0.51 | 0.43 | 0.42 | - | 0.42 | 0.43 |
| Profit Margin | 0.35 | 0.31 | 0.33 | 0.29 | 0.30 | 0.31 |
| EBITDA | 160.11 Billion | 101.95 Billion | 115.93 Billion | - | 107.48 Billion | 114 Billion |
| Earnings Before Tax Margin | 0.51 | 0.43 | 0.42 | 0.37 | 0.41 | 0.42 |
EWC
SYR
TY-P
PR
002213
CIRCHE